(Q24655912)

2

0 references

Hiroaki Taguchi

3

0 references

Maria Salas

4

0 references

Carl Hanson

5

0 references

Sudhir Paul

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

6

0 references

language of work or name

English

0 references

publication date

June 2008

0 references

published in

Autoimmunity Reviews

0 references

volume

7

0 references

issue

6

0 references

page(s)

473-9

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

gp120- and TNF-alpha-induced modulation of human B cell function: proliferation, cyclic AMP generation, Ig production, and B-cell receptor expression

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Antibodies to the superantigenic site of HIV-1 gp120: hydrolytic and binding activities of the light chain subunit

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

HIV evolution and escape.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Perils at mucosal front lines for HIV and SIV and their hosts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Human endogenous retroviruses in the primate lineage and their influence on host genomes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Antibodies as defensive enzymes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Cross-clade HIV-1 neutralization by an antibody fragment from a lupus phage display library

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

On the origin and evolution of the human immunodeficiency virus (HIV).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Innate antibody catalysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

The moving target: mechanisms of HIV persistence during primary infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies. A host factor in homosexual HIV-1 transmission

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

False-positive human immunodeficiency virus testing in patients with lupus erythematosus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Molecular selection of human antibodies with an unconventional bacterial B cell antigen.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Mapping the Ig superantigen-binding site of HIV-1 gp120.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

B cell superantigens: possible roles in immunodeficiency and autoimmunity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Binding of glycoprotein 120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Dna-specific catalytic antibodies in human blood sera

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

A mechanism-based probe for gp120-Hydrolyzing antibodies

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

Expression of endogenous HIV-1 crossreactive antigens within normal human extravillous trophoblast cells

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2527403

The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus

28 November 2018

1 reference

12 December 2020

New evidence for transmitter role of VIP in the airways: impaired relaxation by a catalytic antibody

1 reference

12 December 2020

Cross-Clade HIV-1–Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1–Exposed, Persistently Seronegative Subjects

1 reference

12 December 2020

Carrier-dependent specificity of antibodies to a conserved peptide determinant of gp120

1 reference

12 December 2020

Intravenous immunoglobulins in infectious diseases: where do we stand?

1 reference

12 December 2020

Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120

1 reference

12 December 2020

Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody

1 reference

12 December 2020

Site-directed mutagenesis of proteolytic antibody light chain

1 reference

12 December 2020

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

1 reference

12 December 2020

Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection

1 reference

12 December 2020

Structural basis of the gp120 superantigen-binding site on human immunoglobulins

1 reference

12 December 2020

Towards irreversible HIV inactivation: stable gp120 binding by nucleophilic antibodies

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2008.04.002

7 January 2021